急性轻症急性胰腺炎临床路径应用评价和变异因素分析  

Evaluation and Variation Analysis of Clinical Pathway for Mild Acute Pancreatitis

作　　者：陈学平[1] 罗志刚[1] 曹丽玲[1] 程思根[1] 杨姝[1] 张琳英[1] 高燕云[1] 虞弘[1] 冯燕[1] 

机构地区：[1]云南省昆明市第一人民医院消化内科,650011

出　　处：《医学理论与实践》2014年第9期1123-1124,1132,共3页The Journal of Medical Theory and Practice

摘　　要：目的:评价急性轻症急性胰腺炎临床路径实施效果,对变异因素进行分析。方法:选取住院急性轻症急性胰腺炎患者为研究对象,分为临床路径组和对照组,对两组患者的住院天数、医疗费用、满意度进行比较,对临床路径组的变异因素进行分析。结果:临床路径组患者的住院天数、医疗费用较对照组明显下降,125例进入临床路径患者中117例完成临床路径(93.6%),8例因变异退出临床路径(6.4%),变异因素中以医生因素所致变异发生率最高(32.42%)。结论:急性轻症胰腺临床路径能缩短住院时间,降低医疗费用。在临床路径实施过程中出现变异是不可避免的,大多数变异并不影响临床路径的继续完成,但必须对可控制变异因素进行整改,促进临床路径的顺利实施和改进。Objective：To evaluate effectiveness of clinical pathway in patients with mild acute pancreatitis.And to analyze the causes of variance.Methods：We enrolled patients with mild acute pancreatitis for our research subjects,and allocated these patients to the clinical pathway group and the control group.Length of hospitalization,medical expense and the degree of satisfaction were compared between these two groups.And analyze the causes of variance for the clinical pathway group.Results：Patients in clinical pathway group had significantly decreased length of hospitalization and medical expenses.Among the 125patients,117patients case had completed Clinical Pathway（93.6%）,8patients terminated pathway due to variation.Medical personnel factor is the very common in the causes of variance（32.42%）. Conclusion：The application of clinical pathway in patients with mild acute pancreatitis can reduce Length of hospitalization and medical expense.Variation is inevitable during the application of clinical pathway,but most variation do not affect the completion of the path.The management of controllable variation must be strengthened,so that the application of clinical pathway should be smooth going and make better.

关 键 词：急性轻症急性胰腺炎 临床路径 效果 变异因素 

分 类 号：R576[医药卫生—消化系统]